← Open Payments lookup

LORI DWYER: Open Payments

NPI 1770604282 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,506 in 85 payments from 14 companies in 2025. Trend: 2023 $797 · 2024 $1,532 · 2025 $1,506

Food & beverage: $1,506
CompanyPaymentsAmount
Novo Nordisk Inc13$282
Astellas Pharma US Inc10$238
AstraZeneca Pharmaceuticals LP11$206
Amgen Inc.20$196
PFIZER INC.9$136
Lilly USA, LLC5$106
Abbott Laboratories4$92
ABBVIE INC.5$89
GlaxoSmithKline, LLC.3$55
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$32

Products named: Veozah, OTEZLA, AIRSUPRA, Ozempic, MOUNJARO, Rybelsus, FREESTYLE LIBRE 3, ELIQUIS.

Industry payments across PA — which companies pay providers there.